Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1981-06-26
1983-08-09
Daus, Donald G.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544392, 544396, 544399, 544358, 542440, A61K 31495, C07D29510, C07D29516
Patent
active
043978550
ABSTRACT:
New 4-(substituted-.alpha., .alpha.-dimethyl-1-piperazine pentanoic acids and derivatives which are useful as anti-arteriosclerotic agents are disclosed. These compounds elevate the high density lipoprotein fraction of cholesterol, and also lower the low density lipoprotein fraction of cholesterol.
REFERENCES:
patent: 3658821 (1972-04-01), Fauran et al.
patent: 3753984 (1973-08-01), Fauran et al.
patent: 4007282 (1977-02-01), Mauz et al.
patent: 4125612 (1978-11-01), Sherlock
patent: 4153794 (1979-05-01), Ishiguro
patent: 4239759 (1980-12-01), Gante et al.
Maxwell et al., "Effects of Gemfibrozil . . . ", Artery 4(4): 303-313 (1978).
Zikolova et al., "Synthesis of Pyrazine Derivatives", Chem. Abst. 84: 59388v.
Irikura, 1(3-phenylpropyl)-4-(acyl)piperazine, Chem. Abst. 86: 89893q.
Holmes et al., Drugs Affecting Lipid Metabolism, pp. 45-47, and 85 (1969).
Daignault Ronald A.
Daus Donald G.
Hendricks G.
Warner-Lambert & Company
LandOfFree
4-(Substituted)-.alpha., .alpha.-dimethyl-1-piperazine pentanoic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-(Substituted)-.alpha., .alpha.-dimethyl-1-piperazine pentanoic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-(Substituted)-.alpha., .alpha.-dimethyl-1-piperazine pentanoic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-586901